Respiratory effects of halothane and AMPA receptor antagonist synergy in rats

European Journal of Pharmacology

Volumn 342, Issue 2-3, 1998, Pages 261-265

  Shimazu, Yoshihiro ^a   Umemura, Kazuo ^a   Kawano, Ken Ichi ^a   Hokamura, Kazuya ^a   Kawazura, Hiroshi ^a   Nakashima, Mitsuyoshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

AMPA receptor antagonist; Halothane; NMDA receptor antagonist; Respiration; Respiratory rate

Indexed keywords

6 (1 IMIDAZOLYL) 7 NITRO 2,3 QUINOXALINEDIONE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; DIZOCILPINE; HALOTHANE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; BREATHING RATE; CONTROLLED STUDY; INHALATION ANESTHESIA; INTRAVENOUS DRUG ADMINISTRATION; LUNG MINUTE VOLUME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATION DEPRESSION; TIDAL VOLUME;

ANESTHETICS, INHALATION; ANIMALS; BLOOD GAS ANALYSIS; DIZOCILPINE MALEATE; DRUG SYNERGISM; EXCITATORY AMINO ACID ANTAGONISTS; HALOTHANE; HEMODYNAMIC PROCESSES; MALE; QUINOXALINES; RATS; RATS, WISTAR; RECEPTORS, AMPA; RESPIRATORY MECHANICS;

EID: 0032567705     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01484-2     Document Type: Article

References (21)

1. Abrahams T.P., Taveira-DaSilva A.M., Hamosh P., McManigle J.E., Gillis R.A. Cardiorespiratory effects produced by blockade of excitatory amino acid receptors in cats. Eur. J. Pharmacol. 238:1993;223-233.
2. Amis T.C., Kurpershoek C. Tidal breathing flow-volume loop analysis for clinical assessment of airway obstruction in conscious dogs. Am. J. Vet. Res. 47:1986;1002-1106.
3. Carlá V., Moroni F. General anaesthetics inhibit the responses induced by glutamate receptor antagonists in the mouse cortex. Neurosci. Lett. 146:1992;21-24.
4. Cassus-Soulanis S., Foutz A.S., Denavit-Saubié M. Involvement of NMDA receptors in inspiratory termination in rodents: Effects of wakefulness. Brain Res. 679:1995;25-33.
5. Choi D.W. Glutamate neurotoxicity and disease of the nervous system. Neuron. 1:1988;623-634.
6. Foutz A.S., Champagnat J., Denavit-Saubié M. N-Methyl-D-asparate (NMDA) receptors control respiratory off-switch in cat. Neurosci. Lett. 146:1988;221-226.
7. Foutz A.S., Pierrefiche O., Denavit-Saubié M. Combined blockade of NMDA and non-NMDA receptors produces respiratory arrest in the adult cat. Neuroreport. 5:1994;481-484.
8. Gill R., Brazell C., Woodruff G.N., Kemp J.A. The neuroprotective action of dizocilpine (MK-801) in the rat middle cerebral artery occlusion model of focal ischaemia. Br. J. Pharmacol. 103:1991;2030-2036.
9. Gill R., Nordholm L., Lodge G. The neuroprotective actions of 2,3-dihydroxy-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model. Brain Res. 580:1992;35-43.
10. Greer J.J., Smith J.C., Feldman J.L. Role of excitatory amino acids in the generation and transmission of respiratory drive in neonatal rat. J. Physiol. 437:1991;727-749.
11. Koek W., Woods J.H., Winger G.D. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J. Pharmacol. Exp. Ther. 245:1988;969-974.
12. Liu G., Feldman J.L., Smith J.C. Excitatory amino acid-mediated transmission of inspiratory drive to phrenic motoneurons. J. Neurophysiol. 64:1990;423-436.
13. McManigle J.E., Taveira DaSilva A.M., Dretchen K.L., Gillis R.A. Potentiation of MK-801-induced breathing impairment by 2, 3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline. Eur. J. Pharmacol. 252:1994;11-17.
14. Meldrum B., Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11:1990;379-387.
15. Monteau R., Gauthier P., Rega P., Hilaire G. Effects of N-methyl-D-aspartate (NMDA) antagonist MK-801 on breathing pattern in rats. Neurosci. Lett. 109:1990;134-139.
16. Pierrefiche O., Schmid K., Foutz A.S., Denavit-Saubié M.M. Endogenous activation of NMDA and non-NMDA glutamate receptors on respiratory neurons in cat medulla. Neuropharmacology. 30:1991;429-440.
17. Pierrefiche O., Foutz A.S., Champagnat J., Denavit-Saubié M. NMDA and non-NMDA receptors may play distinct roles in timing mechanisms and transmission in the feline respiratory network. J. Physiol. 474:1994;509-523.
18. Sheardown M.J., Nielsen E.O., Hansen A.J., Jacobsen P., Honoré T. 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: A neuroprotectant for cerebral ischemia. Science. 247:1990;571-574.
19. Shimizu-Sasamata M., Kawasaki-Yatsugi S., Okada M., Sakamoto S., Yatsugi S., Togami J., Hatanaka K., Ohmori J., Koshiya K., Ushida S., Murase K. YM90K: Pharmacological characterization as a selective and potent α-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist. J. Pharmacol. Exp. Ther. 276:1996;84-92.
20. Swan J.H., Meldrum B.S. Protection by NMDA antagonists against selective cell loss following transient ischaemia. J. Cereb. Blood Flow Metab. 10:1990;343-351.
21. Yatsugi S., Takahashi M., Kawasaki-Yatsugi S., Koshiya K., Sakamoto S., Uematsu D., Shimizu-Sasamata M. Neuroprotective effect of YM90K, a novel AMPA/kainate receptor antagonist, in focal cerebral ischemia in cats. J. Cereb. Blood Flow Metab. 16:1996;959-966.